Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15

NCT01173887 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Adult T-cell Leukemia-Lymphoma

Interventions

DRUG: VCAP/AMP/VECP(mLSG15)
BIOLOGICAL: KW-0761

Sponsor

Kyowa Kirin Co., Ltd.